{"title":"Finding the Pieces to Treat the Whole: Using Radiomics to Identify Tumor Habitats.","authors":"Hersh Sagreiya","doi":"10.1148/ryai.230547","DOIUrl":"10.1148/ryai.230547","url":null,"abstract":"","PeriodicalId":29787,"journal":{"name":"Radiology-Artificial Intelligence","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10982906/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139984066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jiye G Kim, Bryan Haslam, Abdul Rahman Diab, Ashwin Sakhare, Giorgia Grisot, Hyunkwang Lee, Jacqueline Holt, Christoph I Lee, William Lotter, A Gregory Sorensen
{"title":"Development and Validation of a Deep Learning Model to Reduce the Interference of Rectal Artifacts in MRI-based Prostate Cancer Diagnosis.","authors":"Lei Hu, Xiangyu Guo, Dawei Zhou, Zhen Wang, Lisong Dai, Liang Li, Ying Li, Tian Zhang, Haining Long, Chengxin Yu, Zhen-Wei Shi, Chu Han, Cheng Lu, Jungong Zhao, Yuehua Li, Yunfei Zha, Zaiyi Liu","doi":"10.1148/ryai.230362","DOIUrl":"10.1148/ryai.230362","url":null,"abstract":"<p><p>Purpose To develop an MRI-based model for clinically significant prostate cancer (csPCa) diagnosis that can resist rectal artifact interference. Materials and Methods This retrospective study included 2203 male patients with prostate lesions who underwent biparametric MRI and biopsy between January 2019 and June 2023. Targeted adversarial training with proprietary adversarial samples (TPAS) strategy was proposed to enhance model resistance against rectal artifacts. The automated csPCa diagnostic models trained with and without TPAS were compared using multicenter validation datasets. The impact of rectal artifacts on the diagnostic performance of each model at the patient and lesion levels was compared using the area under the receiver operating characteristic curve (AUC) and the area under the precision-recall curve (AUPRC). The AUC between models was compared using the DeLong test, and the AUPRC was compared using the bootstrap method. Results The TPAS model exhibited diagnostic performance improvements of 6% at the patient level (AUC: 0.87 vs 0.81, <i>P</i> < .001) and 7% at the lesion level (AUPRC: 0.84 vs 0.77, <i>P</i> = .007) compared with the control model. The TPAS model demonstrated less performance decline in the presence of rectal artifact-pattern adversarial noise than the control model (ΔAUC: -17% vs -19%, ΔAUPRC: -18% vs -21%). The TPAS model performed better than the control model in patients with moderate (AUC: 0.79 vs 0.73, AUPRC: 0.68 vs 0.61) and severe (AUC: 0.75 vs 0.57, AUPRC: 0.69 vs 0.59) artifacts. Conclusion This study demonstrates that the TPAS model can reduce rectal artifact interference in MRI-based csPCa diagnosis, thereby improving its performance in clinical applications. <b>Keywords:</b> MR-Diffusion-weighted Imaging, Urinary, Prostate, Comparative Studies, Diagnosis, Transfer Learning Clinical trial registration no. ChiCTR23000069832 <i>Supplemental material is available for this article.</i> Published under a CC BY 4.0 license.</p>","PeriodicalId":29787,"journal":{"name":"Radiology-Artificial Intelligence","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10985636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katharina V Hoebel, Christopher P Bridge, Sara Ahmed, Oluwatosin Akintola, Caroline Chung, Raymond Y Huang, Jason M Johnson, Albert Kim, K Ina Ly, Ken Chang, Jay Patel, Marco Pinho, Tracy T Batchelor, Bruce R Rosen, Elizabeth R Gerstner, Jayashree Kalpathy-Cramer
Gianfranco Di Salle, Lorenzo Tumminello, Maria Elena Laino, Sherif Shalaby, Gayane Aghakhanyan, Salvatore Claudio Fanni, Maria Febi, Jorge Eduardo Shortrede, Mario Miccoli, Lorenzo Faggioni, Mirco Cosottini, Emanuele Neri
{"title":"Accuracy of Radiomics in Predicting <i>IDH</i> Mutation Status in Diffuse Gliomas: A Bivariate Meta-Analysis.","authors":"Gianfranco Di Salle, Lorenzo Tumminello, Maria Elena Laino, Sherif Shalaby, Gayane Aghakhanyan, Salvatore Claudio Fanni, Maria Febi, Jorge Eduardo Shortrede, Mario Miccoli, Lorenzo Faggioni, Mirco Cosottini, Emanuele Neri","doi":"10.1148/ryai.220257","DOIUrl":"10.1148/ryai.220257","url":null,"abstract":"<p><p>Purpose To perform a systematic review and meta-analysis assessing the predictive accuracy of radiomics in the noninvasive determination of isocitrate dehydrogenase <i>(IDH</i>) status in grade 4 and lower-grade diffuse gliomas. Materials and Methods A systematic search was performed in the PubMed, Scopus, Embase, Web of Science, and Cochrane Library databases for relevant articles published between January 1, 2010, and July 7, 2021. Pooled sensitivity and specificity across studies were estimated. Risk of bias was evaluated using Quality Assessment of Diagnostic Accuracy Studies-2, and methods were evaluated using the radiomics quality score (RQS). Additional subgroup analyses were performed according to tumor grade, RQS, and number of sequences used (PROSPERO ID: CRD42021268958). Results Twenty-six studies that included 3280 patients were included for analysis. The pooled sensitivity and specificity of radiomics for the detection of <i>IDH</i> mutation were 79% (95% CI: 76, 83) and 80% (95% CI: 76, 83), respectively. Low RQS scores were found overall for the included works. Subgroup analyses showed lower false-positive rates in very low RQS studies (RQS < 6) (meta-regression, <i>z</i> = -1.9; <i>P</i> = .02) compared with adequate RQS studies. No substantial differences were found in pooled sensitivity and specificity for the pure grade 4 gliomas group compared with the all-grade gliomas group (81% and 86% vs 79% and 79%, respectively) and for studies using single versus multiple sequences (80% and 77% vs 79% and 82%, respectively). Conclusion The pooled data showed that radiomics achieved good accuracy performance in distinguishing <i>IDH</i> mutation status in patients with grade 4 and lower-grade diffuse gliomas. The overall methodologic quality (RQS) was low and introduced potential bias. <b>Keywords:</b> Neuro-Oncology, Radiomics, Integration, Application Domain, Glioblastoma, IDH Mutation, Radiomics Quality Scoring <i>Supplemental material is available for this article.</i> Published under a CC BY 4.0 license.</p>","PeriodicalId":29787,"journal":{"name":"Radiology-Artificial Intelligence","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831518/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139478904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tina Yao, Nicole St Clair, Gabriel F Miller, Adam L Dorfman, Mark A Fogel, Sunil Ghelani, Rajesh Krishnamurthy, Christopher Z Lam, Michael Quail, Joshua D Robinson, David Schidlow, Timothy C Slesnick, Justin Weigand, Jennifer A Steeden, Rahul H Rathod, Vivek Muthurangu